Dangerous Liaisons between Beta-Amyloid and Cholinergic Neurotransmission

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|15|2525-2538

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2525-2538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clearance of Beta-Amyloid in the Brain

By  

Current Medicinal Chemistry, Vol. 21, Iss. 35, 2014-11 ,pp. : 4085-4090

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4377-4387

Bentham Science Publishers

Access to resources Recommend Favorite

beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Nitric Oxide Modulates Cholinergic Neurotransmission in Cat Duodenum

By Sotirov E.   Dobreva G.   Noeva A.   Papasova M.  

General Pharmacology, Vol. 27, Iss. 2, 1996-03 ,pp. : 395-398

Elsevier

Access to resources Recommend Favorite

Simvastatin alters membrane cholesterol distribution and beta-amyloid levels in brains of female APP751SL mice

By Eckert G. P.   Reik C.   Müller W. E.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 7, 2013-07 ,pp. : 590-594

Govi-Verlag

Access to resources Recommend Favorite